verified SJR 0,324 · Q3 • database Scopus / SJR & Web of Science indexed

United States · Lippincott Williams and Wilk...

workspace_premium Q3 — Hematology lock Subscription

Journal of Pediatric Hematology/Oncology

Journal of Pediatric Hematology/Oncology is a journal indexed in SJR in Hematology and Oncology with an H index of 88. It has an SJR impact factor of 0,324 and it has a best quartile of Q3. It is published in English. It has an SJR impact factor of 0,324.

Journal of Pediatric Hematology/Oncology focuses its scope in these topics and keywords: cell, pediatric, hematopoietic, homozygous, children, unrelated, lymphohistiocytosis, cardiomyopathy, childattitudes, endoflifecare, ...

ISSN: 1077-4114

Publisher: Lippincott Williams and Wilkins

Category: Hematology

Indexation: verifiedScopus / SJR verifiedWeb of Science

open_in_new Portal NPD menu_book Guidelines NPD

schedule CountryOfPapers database fields

SJR Impact Factor trending_up

0,324 Q3

H-index 88

Acceptance rate pie_chart

26% Selective

Source Acceptance_Rate

Time to publication hourglass_top

NPD

Field NPD

Publication cost (APC) payments

NPD Subscription

Non-OA path NPD

Metrics

Scimago and CountryOfPapers database fields

Scopus / SJR Web of Science

SJR Impact

0,324

H-index

Docs (year)

194

Docs 3y

971

Total refs

4851

Cites 3y

810

Citable 3y

897

Cites/Doc 2y

0.78

Ref/Doc

25.01

Immediate OA

—

Embargoed OA

NPD

Non OA / Submission

—

shield Researcher voice

Name good journals. Call out predatory ones.

Share what peer review, fees, and timelines were really like. Praise fair editors. Flag APC traps, fake metrics, or spam solicitations — with facts from your submission.

Fair & fast peer review Clear APC / no surprise fees Suspected predatory Fake impact claims

rate_review Write an honest review

Researcher reviews

sentiment_dissatisfied No reviews yet — be the first to share an honest experience.

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID * * Only to validate authenticity — identity is not shown publicly.

Best articles by citations

Antithymocyte Globulin Pharmacokinetics in Pediatric Patients After Hematopoietic Stem Cell Transplantation

Value of Electronic Data for Model Validation and Refinement: Bacteremia Risk in Children With Fever and Neutropenia

Chromosome Abnormalities May Correlate With Prognosis in Burkitt/Burkitt-Like Lymphomas of Children and Adolescents

Chemotherapy-induced Alteration of SDF-1/CXCR4 Expression in Bone Marrow-derived Mesenchymal Stem Cells From Adolescents and Young Adults With Acute Lymphoblastic Leukemia

Chediak-Higashi Syndrome

Cerebrovascular Complications of l-Asparaginase in the Therapy of Acute Lymphoblastic Leukemia

Central Nervous System Pharmacology of Antileukemic Drugs

Cancer Occurrence in Southeast Asian Children in California

Bacillus cereus Central Line Infection in an Immunocompetent Child With Hemophilia

Bacillus cereus Causing Fulminant Sepsis and Hemolysis in Two Patients With Acute Leukemia

Autoimmune Thyroiditis After Bone Marrow Transplantation in a Boy With Wiskott-Aldrich Syndrome

Autoimmune Hemolytic Anemia in Children

SHOW MORE ARTICLES

Assessment of Cerebral Tissue Oxygenation in Patients With Sickle Cell Disease: Effect of Transfusion Therapy

A Basic Classification and a Comprehensive Examination of Pediatric Myeloproliferative Syndromes

Antibiotic-Resistant Pneumococcal Infection in Children with Sickle Cell Disease in the United States

Alveolar Rhabdomyosarcoma With Concurrent Metastases to Bone Marrow and Lymph Nodes Simulating Acute Hematologic Malignancy

Allogeneic Bone Marrow Transplantation in Juvenile Myelomonocytic Leukemia Without Total Body Irradiation

Adjuvant Chemotherapy With Vincristine, Doxorubicin, and Cyclophosphamide in the Treatment of Postenucleation High Risk Retinoblastoma

Acute Myelogenous Leukemia and Glycogen Storage Disease 1b

Acquired Glanzmann??s Thrombasthenia Associated With Acute Lymphoblastic Leukemia

A Prospective Double-Blind Randomized Trial of Urokinase Flushes to Prevent Bacteremia Resulting From Luminal Colonization of Subcutaneous Central Venous Catheters

A Comprehensive Study of the Neonatal Manifestations of Congenital Dyserythropoietic Anemia Type I

A Comparison of Pain Assessment Measures in Pediatric Sickle Cell Disease

A Comparative Assessment of Attendance and Nonattendance at Camp Trillium by Children With Cancer and Their Families; Including Their Utilization of Health and Social Services

FAQs

Journal of Pediatric Hematology/Oncology has an SJR of 0,324 (best quartile Q3) in the CountryOfPapers database.

Immediate OA APC is not available (NPD).

The acceptance rate recorded for Journal of Pediatric Hematology/Oncology is 26%.

Journal of Pediatric Hematology/Oncology

Metrics

Name good journals. Call out predatory ones.

Researcher reviews

Best articles by citations

FAQs

What is the SJR of Journal of Pediatric Hematology/Oncology?

What is the APC / publication cost?

What is the acceptance rate?